Application Development
We help you build complex genomic software for managing and
analyzing data and metadata from the entire gamut of omics
modalities. We can help you accelerate releases and scale software
operations.
Product Development
We have a strong track record in product development for complex Genomic Applications, e.g., GeneSpring and MassProfiler Pro, for Agilent and StrandNGS. We extend our software development services to US-based large diagnostics, instrument, and reagent companies. We are an Illumina ICA implementation partner and have similar relationships with Agilent as well as a large pharma and diagnostics company, to name only 3 of our notable clientele.
and Validation (CDx/IVD)
We have deep experience building and validating algorithms and software accompanying NGS assays, including generating hand-crafted test cases and clinical-grade documentation.
Development for Internal Use
We leverage our expertise in secondary and tertiary NGS software to build custom tools to empower our India clinical diagnostics business.
StrandNGS is our integrated platform for NGS secondary analysis, management, and visualization.
StrandOmics is our HIPAA-compliant platform for variant classification and interpretation, thus powering NGS tertiary analysis.
Together, StrandNGS and StrandOmics enable secondary analysis and variant reporting from somatic, inherited cancer risk and rare disease exome panels spanning ≈10,000 tests per annum.
Software Solutions
Strand develops tailored software tools and solutions to accompany molecular biology kits and equipment.
QXDx BCR-ABL
Reporter
Strand has developed the QXDx BCR-ABL Reporter tool for customers of Bio-Rad Laboratories’ QXDx™ BCR-ABL %IS (CE-IVD) Kit. The kit enables the detection and monitoring of BCR-ABL fusions in patients with Chronic Myeloid Leukemia.
Partner
Strand is an official Illumina Connected Analytics (ICA) Implementation Partner, and we’re equipped with software, bioinformatics, and systems integration capabilities to aid ICA customers.
Frequently Asked
Questions
for more information.
See for more information.
See for more information.
See for more information.
See for more information.